Guillain-Barré syndrome and chikungunya: Description of all cases diagnosed during the 2014 outbreak in the French West Indies

American Journal of Tropical Medicine and Hygiene

Volumn 97, Issue 2, 2017, Pages 356-360

  Balavoine, Stephanie ^a   Pircher, Mathilde ^b   Hoen, Bruno ^a,c   Herrmann Storck, Cecile ^a   Najioullah, Fatiha ^b   Madeux, Benjamin ^a   Signate, Aissatou ^b   Valentino, Ruddy ^b   Lannuzel, Annie ^a,c,d   Louis, Magali Saint ^a   Cassadou, Sylvie ^e   Cabié, Andre ^a,b,c   Schepers, Kinda ^a  

^a Centre Hospitalier Universitaire Pointe a Pitre   (Guadeloupe)

^b Centre Hospitalier Universitaire   (France)

^c UNIVERSITÉ DES ANTILLES   (France)

^d SORBONNE UNIVERSITÉ   (France)

^e SANTÉ PUBLIQUE FRANCE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN;

ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; AUTONOMIC DYSFUNCTION; CARIBBEAN ISLANDS; CHIKUNGUNYA; CLINICAL ARTICLE; CONVALESCENCE; DYSARTHRIA; EPIDEMIC; FATIGUE; FEMALE; FOLLOW UP; GUILLAIN BARRE SYNDROME; HAND PARESTHESIA; HEADACHE; HUMAN; INCIDENCE; MALE; MIDDLE AGED; NEUROPATHY; PLASMA EXCHANGE; SYMPTOM; TREATMENT RESPONSE; VERY ELDERLY; CHIKUNGUNYA FEVER; COMPLICATION; GUADELOUPE; GUILLAIN-BARRE SYNDROME; MARTINIQUE; PREVALENCE; STATISTICS AND NUMERICAL DATA;

ADULT; CHIKUNGUNYA FEVER; DISEASE OUTBREAKS; FEMALE; GUADELOUPE; GUILLAIN-BARRE SYNDROME; HUMANS; INCIDENCE; MALE; MARTINIQUE; MIDDLE AGED; PREVALENCE;

EID: 85026870663     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.15-0753     Document Type: Article

References (22)

1. Cassadou S, Boucau S, Petit-Sinturel M, Huc P, Leparc-Goffart I, Ledrans M, 2014. Emergence of chikungunya fever on the French side of Saint Martin island, October to December 2013. Euro Surveill 19: 13.
2. Thiberville S-D, Moyen N, Dupuis-Maguiraga L, Nougairede A, Gould EA, Roques P, de Lamballerie X, 2013. Chikungunya fever: Epidemiology, clinical syndrome, pathogenesis and therapy. Antiviral Res 99: 345-370.
3. van den Berg B, Walgaard C, Drenthen J, Fokke C, JacobsBC, van Doorn PA, 2014. Guillain-Barre syndrome: Pathogenesis, diagnosis, treatment and prognosis. Nat Rev Neurol 10: 469-482.
4. vanDoornPA, RutsL, JacobsBC, 2008.Clinical features, pathogenesis, andtreatmentofGuillain-Barré syndrome. Lancet Neurol 7:939-950.
5. SahuR, VermaR, JainA, GargRK, SinghMK, MalhotraHS, Sharma PK, Parihar A, 2014. Neurologic complications in dengue virus infection: A prospective cohort study. Neurology 83: 1601-1609.
6. Davis LE, DeBiasiR, GoadeDE, HaalandKY, Harrington JA, Harnar JB, Pergam SA, King MK, DeMasters BK, Tyler KL, 2006. West Nile virus neuroinvasive disease. Ann Neurol 60: 286-300.
7. Lebrun G, Chadda K, Reboux A-H, Martinet O, Gaüzère B-A, 2009. Guillain-Barré syndrome after chikungunya infection. Emerg Infect Dis 15: 495.
8. Oehler E, Fournier E, Leparc-Goffart I, Larre P, Cubizolle S, Sookhareea C, Lastère S, Ghawche F, 2015. Increase in cases of Guillain-Barré syndrome during a chikungunya outbreak, French Polynesia, 2014 to 2015. Euro Surveill 20: 30079.
9. Oehler E, Watrin L, Larre P, Leparc-Goffart I, Lastere S, Valour F, Baudouin L, Mallet H, Musso D, Ghawche F, 2014. Zika virus infection complicated by Guillain-Barre syndrome-case report, French Polynesia, December 2013. Euro Surveill 19: 20720.
10. Asbury AK, Cornblath DR, 1990. Assessment of current diagnostic criteria for Guillain-Barré syndrome. Ann Neurol 27: S21-S24.
11. Hughes RA, Swan AV, van Doorn PA, 2014. Intravenous immunoglobulin forGuillain-Barré syndrome. Cochrane Database Syst Rev. Available at: Http://onlinelibrary.wiley.com/doi/10.1002/14651858. CD002063.pub6/full. Accessed October 5, 2015.
12. Gérardin P, Couderc T, Bintner M, Tournebize P, Renouil M, Lémant J, Boisson V, Borgherini G, Staikowsky F, Schramm F, Lecuit M, Michault A; Encephalchik Study Group, 2016. Chikungunya virus-associated encephalitis: A cohort study on La Réunion Island, 2005-2009. Neurology 86: 94-102.
13. Torres JR, Córdova LG, Saravia V, Arvelaez J, Castro JS, 2015. Nasal skin necrosis: An unexpected new finding in severe chikungunya fever. Clin Infect Dis 62: 78-81.
14. RolléA, Schepers K, Cassadou S, Curlier E, Madeux B, Hermann-StorckC, Fabre I, Lamaury I, TressièresB, ThieryG, HoenB, 2016. Severe sepsis and septic shock associated with chikungunya virus infection, Guadeloupe, 2014. Emerg Infect Dis 22: 891-894.
15. Sivadon-Tardy V, Orlikowski D, Rozenberg F, Caudie C, Sharshar T, Lebon P, Annane D, Raphaël J-C, Porcher R, Gaillard J-L, 2006.Guillain-Barré syndrome, greaterParis area. Emerg Infect Dis 12: 990.
16. Webb AJ, Brain SA, Wood R, Rinaldi S, Turner MR, 2015. Seasonal variation inGuillain-Barré syndrome: A systematic review, meta-analysis and Oxfordshire cohort study. J Neurol Neurosurg Psychiatry 86: 1196-1201.
17. Soares CN, Cabral-CastroM, Oliveira C, Faria LC, Peralta JM, de Freitas MRG, Puccioni-Sohler M, 2008. Oligosymptomatic dengue infection: A potential cause of Guillain Barré syndrome. Arq Neuropsiquiatr 66: 234-237.
18. Kanikannan MAK, Durga P, Venigalla NK, Kandadai RM, Jabeen SA, Borgohain R, 2014. Simple bedside predictors of mechanical ventilation in patients with Guillain-Barré syndrome. J Crit Care 29: 219-223.
19. Rajabally YA, Uncini A, 2012. Outcome and its predictors in Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry 83: 711-718.
20. Teo TH, Her Z, Tan JJ, Lum FM, Lee WW, Chan YH, Ong RY, KamYW, Leparc-Goffart I, Gallian P, Rénia L, de Lamballerie X, Ng LF, 2015. Caribbean and La Réunion chikungunya virus isolates differ in their capacity to induce proinflammatory Th1 and NK cell responses and acute joint pathology. J Virol 89: 7955-7969.
21. Wei Chiam C, Fun Chan Y, Chai Ong K, Thong Wong K, Sam IC, 2015. Neurovirulence comparison of chikungunya virus isolates of the Asian and East/Central/South African genotypes from Malaysia. Gen Virol. 96: 3243-3254.
22. Willison HJ, Jacobs BC, van Doorn PA, 2016. Guillain-Barré syndrome. Lancet 388: 717-727.